LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
-2.53%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$4.19B
AUM Growth
+$4.19B
(-28%)
Cap. Flow
-$1.38B
Cap. Flow
% of AUM
-33%
Top 10 Holdings %
Top 10 Hldgs %
60.37%
Holding
590
New
204
Increased
36
Reduced
84
Closed
160
Top Buys
| 1 |
Qualcomm
QCOM
|
$182M |
| 2 |
Vistra
VST
|
$180M |
| 3 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
$170M |
| 4 |
Micron Technology
MU
|
$148M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$125M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
$413M |
| 2 |
VMW
VMware, Inc
VMW
|
$279M |
| 3 |
Occidental Petroleum
OXY
|
$217M |
| 4 |
eBay
EBAY
|
$211M |
| 5 |
PG&E
PCG
|
$206M |
Sector Composition
| 1 | Healthcare | 25.19% |
| 2 | Technology | 14.33% |
| 3 | Consumer Discretionary | 11.38% |
| 4 | Communication Services | 9.28% |
| 5 | Materials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
VICI Properties
VICI
$35.6B
| $2.08M | 0.03% |
73,200
| – | – |
|
|
THRX
102
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $2.07M | 0.03% |
179,619
-25,402
| -12% | -$293K |
|
|
AERI
103
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.07M | 0.03% |
+227,022
| New | +$2.07M |
|
104
Keurig Dr Pepper
KDP
$39.5B
| $2.05M | 0.03% |
54,000
+17,000
| +46% | +$644K |
|
105
US Bancorp
USB
$75.5B
| $2.04M | 0.02% |
38,273
+7,300
| +24% | +$388K |
|
106
Reynolds Consumer Products
REYN
$4.94B
| $2M | 0.02% |
68,262
-92,100
| -57% | -$2.7M |
|
107
Organogenesis Holdings
ORGO
$629M
| $1.92M | 0.02% |
+252,338
| New | +$1.92M |
|
108
Kura Oncology
KURA
$732M
| $1.89M | 0.02% |
117,433
+67,433
| +135% | +$1.08M |
|
109
Amazon
AMZN
$2.41T
| $1.85M | 0.02% |
566
+466
| +466% | +$1.52M |
|
110
General Motors
GM
$55B
| $1.83M | 0.02% |
41,757
-14,280
| -25% | -$625K |
|
111
Boston Omaha
BOC
$425M
| $1.83M | 0.02% |
71,928
-57,666
| -44% | -$1.46M |
|
112
Crinetics Pharmaceuticals
CRNX
$3.26B
| $1.76M | 0.02% |
+79,952
| New | +$1.76M |
|
|
CTV
113
DELISTED
Innovid Corp.
CTV
| $1.75M | 0.02% |
290,305
-9,695
| -3% | -$58.5K |
|
114
Incyte
INCY
$17B
| $1.74M | 0.02% |
+21,900
| New | +$1.74M |
|
115
Runway Growth Finance
RWAY
$390M
| $1.71M | 0.02% |
125,918
-14,052
| -10% | -$191K |
|
116
Universal Health Services
UHS
$11.6B
| $1.64M | 0.02% |
+11,300
| New | +$1.64M |
|
117
Anebulo Pharmaceuticals
ANEB
$101M
| $1.48M | 0.02% |
219,583
-5,417
| -2% | -$36.6K |
|
118
CVS Health
CVS
$93B
| $1.47M | 0.02% |
+14,500
| New | +$1.47M |
|
|
IACC
119
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
| $1.46M | 0.02% |
150,000
| – | – |
|
120
Surgery Partners
SGRY
$2.89B
| $1.46M | 0.02% |
26,531
-19,559
| -42% | -$1.08M |
|
121
Steris
STE
$23.9B
| $1.43M | 0.02% |
+5,898
| New | +$1.43M |
|
122
Edgewise Therapeutics
EWTX
$1.54B
| $1.37M | 0.02% |
+140,972
| New | +$1.37M |
|
123
Tyson Foods
TSN
$20B
| $1.35M | 0.02% |
15,041
-3,800
| -20% | -$341K |
|
124
IonQ
IONQ
$12.2B
| $1.28M | 0.02% |
100,000
| – | – |
|
|
AVDL
125
Avadel Pharmaceuticals
AVDL
$1.42B
| $1.24M | 0.02% |
+182,000
| New | +$1.24M |
|